Inspire Medical Systems Pre-Tax Profit Margin 2017-2024 | INSP

Inspire Medical Systems pre-tax profit margin from 2017 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Inspire Medical Systems Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-12-31 $0.80B $0.06B 7.35%
2024-09-30 $0.76B $0.04B 4.89%
2024-06-30 $0.71B $0.01B 1.27%
2024-03-31 $0.66B $-0.01B -2.12%
2023-12-31 $0.63B $-0.02B -3.20%
2023-09-30 $0.57B $-0.03B -5.61%
2023-06-30 $0.53B $-0.04B -7.79%
2023-03-31 $0.47B $-0.04B -9.23%
2022-12-31 $0.41B $-0.05B -11.06%
2022-09-30 $0.35B $-0.05B -14.41%
2022-06-30 $0.30B $-0.04B -14.33%
2022-03-31 $0.26B $-0.04B -16.03%
2021-12-31 $0.23B $-0.04B -17.60%
2021-09-30 $0.20B $-0.05B -22.89%
2021-06-30 $0.18B $-0.05B -26.29%
2021-03-31 $0.13B $-0.06B -41.79%
2020-12-31 $0.12B $-0.06B -48.70%
2020-09-30 $0.10B $-0.06B -60.42%
2020-06-30 $0.08B $-0.06B -69.14%
2020-03-31 $0.09B $-0.04B -47.13%
2019-12-31 $0.08B $-0.03B -40.24%
2019-09-30 $0.07B $-0.03B -40.28%
2019-06-30 $0.06B $-0.03B -40.63%
2019-03-31 $0.06B $-0.02B -42.11%
2018-12-31 $0.05B $-0.02B -45.10%
2018-09-30 $0.04B $-0.02B -50.00%
2018-06-30 $0.04B $-0.02B -55.26%
2018-03-31 $0.03B $-0.02B -60.61%
2017-12-31 $0.03B $-0.02B -60.71%
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $4.756B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $38.476B 53.14
Tempus AI (TEM) US $9.826B 0.00
Hims & Hers Health (HIMS) US $9.069B 145.79
IRhythm Technologies (IRTC) US $4.186B 0.00
Privia Health (PRVA) US $2.829B 212.00
Enovis (ENOV) US $2.016B 12.47
Schrodinger (SDGR) US $1.847B 0.00
Clover Health Investments (CLOV) US $1.706B 0.00
Phreesia (PHR) US $1.512B 0.00
Omnicell (OMCL) US $1.460B 31.48
Azenta (AZTA) US $1.232B 57.36
10x Genomics (TXG) US $1.031B 0.00
Fulgent Genetics (FLGT) US $0.634B 0.00
Butterfly Network (BFLY) US $0.566B 0.00
Talkspace (TALK) US $0.537B 319.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.456B 0.00
TruBridge (TBRG) US $0.392B 0.00
Claritev (CTEV) US $0.362B 0.00
Health Catalyst (HCAT) US $0.294B 0.00
Nyxoah SA (NYXH) BE $0.208B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.202B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.116B 0.00
EUDA Health Holdings (EUDA) SG $0.097B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.081B 0.00
CareCloud (CCLD) US $0.080B 3.43
111 (YI) CN $0.072B 0.00
P3 Health Partners (PIII) US $0.063B 0.00
HeartBeam (BEAT) US $0.061B 0.00
Outset Medical (OM) US $0.044B 0.00
Zepp Health (ZEPP) CN $0.039B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Precipio (PRPO) US $0.011B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Healthcare Triangle (HCTI) US $0.009B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.005B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00